The panmictic nature of Neisseria meningitidis serogroup B during a period of endemic disease in Canada

被引:9
作者
Ashton, FE
Caugant, DA
机构
[1] Hlth Canada, Canadian Sci Ctr Human & Anim Hlth, Populat & Publ Hlth Branch, Winnipeg, MB R3E 3P6, Canada
[2] Natl Publ Hlth Inst, WHO, Collaborating Ctr Reference & Res Meningococci, N-0403 Oslo, Norway
关键词
meningococcal; genotypes; serotypes; serosubtypes; Neisseria meningitidis;
D O I
10.1139/cjm-47-4-283
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three hundred and one (301) strains of Neisseria meningitidis serogroup B, isolated from patients with meningococcal disease during the years 1994-1996, were subjected to multilocus enzyme electrophoresis, serotyping, and serosubtyping. Based on the analyses of 14 enzyme loci, 177 electrophoretic types (ETs) were identified. Of these, 136 were represented by single isolates and 41 were represented by multiple isolates (range 2-31). The mean genetic diversity for isolates was 0.444 and for ETs was 0.440. The index of association (I-A) between loci was 0.530 +/- 0.08 for isolates and 0.256 +/- 0.10 for ETs. Cluster analysis revealed the presence of 39 lineages each represented by a single ET or clusters of ETs. The most common serotypes were 4, 15, and 14 and accounted for 84 (28.0%), 53 (17.6%), and 32 (10.6%) of the isolates, respectively, and were dispersed amongst 46 ETs (1-122), 35 ETs (3-165), and 26 ETs (18-76), respectively. The 109 (36.6%) nontypable (NT) isolates were amongst 74 ETs (6-177). The mean genetic diversity for serotypes 4, 15, and 14 and NT isolates was 0.368, 0.371, 0.343, and 0.442, respectively, and for ETs was 0.363, 0.354, 0.397, and 0.440, respectively. Combinations of serotypes and serosubtypes (number of isolates) that occurred most frequently were 4:P1.14 (17), 14:P1.16 (16), NT:P1.16 (16), 15:P1.16 (13), and NT:P1.13 (13). The majority of group B disease in Canada during 1994-1996 was caused by meningococci of considerable genetic diversity, and reflects a situation of endemic disease. However, the results also indicate that organisms belonging to the ET-5 complex, which has been responsible for outbreaks of group B disease globally for several decades, have been introduced into the country.
引用
收藏
页码:283 / 289
页数:7
相关论文
共 46 条
  • [1] WHOLE-CELL ELISA FOR TYPING NEISSERIA-MENINGITIDIS WITH MONOCLONAL-ANTIBODIES
    ABDILLAHI, H
    POOLMAN, JT
    [J]. FEMS MICROBIOLOGY LETTERS, 1987, 48 (03) : 367 - 371
  • [2] CLONAL SPREAD OF SEROGROUP-A MENINGOCOCCI - A PARADIGM FOR THE ANALYSIS OF MICROEVOLUTION IN BACTERIA
    ACHTMAN, M
    [J]. MOLECULAR MICROBIOLOGY, 1994, 11 (01) : 15 - 22
  • [3] SEROTYPES AND SUBTYPES OF NEISSERIA-MENINGITIDIS SEROGROUP-B STRAINS ASSOCIATED WITH MENINGOCOCCAL DISEASE IN CANADA, 1977-1989
    ASHTON, FE
    MANCINO, L
    RYAN, AJ
    POOLMAN, JT
    ABDILLAHI, H
    ZOLLINGER, WD
    [J]. CANADIAN JOURNAL OF MICROBIOLOGY, 1991, 37 (08) : 613 - 617
  • [4] SEROTYPES OF NEISSERIA-MENINGITIDIS ASSOCIATED WITH AN INCREASED INCIDENCE OF MENINGITIS CASES IN THE HAMILTON AREA, ONTARIO, DURING 1978 AND 1979
    ASHTON, FE
    RYAN, JA
    JONES, C
    BRODEUR, BR
    DIENA, BB
    [J]. CANADIAN JOURNAL OF MICROBIOLOGY, 1983, 29 (01) : 129 - 136
  • [5] SEROTYPES AMONG NEISSERIA-MENINGITIDIS SEROGROUP-B AND SEROGROUP-C STRAINS ISOLATED IN CANADA
    ASHTON, FE
    RYAN, A
    DIENA, BB
    MACKENZIE, AMR
    CHAN, F
    [J]. CANADIAN JOURNAL OF MICROBIOLOGY, 1980, 26 (12) : 1480 - 1488
  • [6] EVALUATION OF THE ANTISERUM AGAR METHOD FOR THE SEROGROUP IDENTIFICATION OF NEISSERIA-MENINGITIDIS
    ASHTON, FE
    RYAN, A
    DIENA, BB
    FRASCH, CE
    [J]. CANADIAN JOURNAL OF MICROBIOLOGY, 1979, 25 (06) : 784 - 787
  • [7] EFFECT OF OUTER-MEMBRANE VESICLE VACCINE AGAINST GROUP-B MENINGOCOCCAL DISEASE IN NORWAY
    BJUNE, G
    HOIBY, EA
    GRONNESBY, JK
    ARNESEN, O
    HOLSTFREDRIKSEN, J
    HALSTENSEN, A
    HOLTEN, E
    LINDBAK, AK
    NOKLEBY, H
    ROSENQVIST, E
    SOLBERG, LK
    CLOSS, O
    ENG, J
    FROHOLM, LO
    LYSTAD, A
    BAKKETEIG, LS
    HAREIDE, B
    [J]. LANCET, 1991, 338 (8775) : 1093 - 1096
  • [8] EFFICACY, SAFETY, AND IMMUNOGENICITY OF A MENINGOCOCCAL GROUP-B (15-P1.3) OUTER-MEMBRANE PROTEIN VACCINE IN IQUIQUE, CHILE
    BOSLEGO, J
    GARCIA, J
    CRUZ, C
    ZOLLINGER, W
    BRANDT, B
    RUIZ, S
    MARTINEZ, M
    ARTHUR, J
    UNDERWOOD, P
    SILVA, W
    MORAN, E
    HANKINS, W
    GILLY, J
    MAYS, J
    [J]. VACCINE, 1995, 13 (09) : 821 - 829
  • [9] BOVRE K, 1980, NIPH (National Institute of Public Health) Annals (Oslo), V3, P9
  • [10] CARTWRIGHT KAV, 1986, LANCET, V2, P558